EPS: As of FY2025 Q2, the actual value is USD 0.06.<h3>Segment Revenue</h3><ul><li>Public Units: 15,000,000 units sold at $10.00 per unit, generating gross proceeds of $150,000,000.</li><li>Private Placement Units: 500,000 units sold at $10.00 per unit, generating gross proceeds of $5,000,000.</li></ul><h3>Operational Metrics</h3><ul><li>Net Income: $808,306 for the three months ended June 30, 2025, and $758,164 for the period from January 9, 2025 (inception) through June 30, 2025.</li><li>General and Administrative Costs: $185,052 for the three months ended June 30, 2025, and $235,194 for the period from January 9, 2025 (inception) through June 30, 2025.</li><li>Interest Earned on Marketable Securities Held in Trust Account: $834,274 for the period from January 9, 2025 (inception) through June 30, 2025.</li></ul><h3>Cash Flow</h3><ul><li>Net Cash Used in Operating Activities: - $385,773 for the period from January 9, 2025 (inception) through June 30, 2025.</li><li>Net Cash Used in Investing Activities: - $150,000,000 for the period from January 9, 2025 (inception) through June 30, 2025.</li><li>Net Cash Provided by Financing Activities: $151,497,148 for the period from January 9, 2025 (inception) through June 30, 2025.</li></ul><h3>Unique Metrics</h3><ul><li>Marketable Securities Held in Trust Account: $150,834,274 as of June 30, 2025.</li><li>Cash: $1,111,375 as of June 30, 2025.</li></ul><h3>Future Outlook and Strategy</h3><ul><li>Core Business Focus: The company intends to effectuate its Business Combination using cash derived from the proceeds of the Initial Public Offering and the Private Placement, securities, debt, or a combination of cash, securities, and debt.</li><li>Non-Core Business: The company may seek to extend the Combination Period consistent with applicable laws, regulations, and stock exchange rules by amending its Amended and Restated Articles, which would require the approval of Public Shareholders and provide them the opportunity to redeem all or a portion of their Public Shares in connection with the vote on such approval.</li><li>Priority: The company aims to complete its initial Business Combination within the Combination Period, and if unable to do so, it may seek shareholder approval to extend the period, which could affect its ability to maintain its Nasdaq listing.</li></ul>

EGH ACQUISITION CORP COM USD0.0001(S/R 08/05/2025) | 10-Q: FY2025 Q2 EPS: USD 0.06